543 results on '"Ohtani, Tomohito"'
Search Results
2. Lower doses of carvedilol in Japanese heart failure patients with reduced ejection fraction could show the potential to be non-inferior to higher doses in US patients: An international collaborative observational study.
3. A case of cardiac sarcoidosis mimicking arrhythmogenic right ventricular cardiomyopathy
4. Correction: Novel indices representing heterogeneous distributions of myocardial perfusion imaging
5. Ratio of pulmonary artery diameter to ascending aortic diameter and its association with right ventricular failure after left ventricular assist device implantation
6. Reliability of transient elastography as a noninvasive method for estimating central venous pressure in adult patients after a Fontan procedure
7. JCS/JSCVS/JCC/CVIT 2023 guideline focused update on indication and operation of PCPS/ECMO/IMPELLA.
8. Oral nutritional supplements in older outpatients with heart failure: rationale and design of the ALIMENT‐HF trial
9. Multiple percutaneous coronary interventions worsen outcomes for subsequent surgical correction of chronic ischemic mitral regurgitation
10. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy
11. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
12. Focal severe decrease in myocardial technetium-99 m sestamibi uptake indicates ventricular irreversibility in patients with dilated cardiomyopathy
13. Differences in routes of guiding catheters for left coronary artery according to access sites assessed by the combined angiography-computed tomography system
14. Abstract 13725: The Dose Difference of Carvedilol for Heart Failure Management Between Asian-Americans and Japanese Could Show No Difference in the Improvement of Heart Function
15. Abstract 10926: Warfarin Dosing Algorithms With the Information on Genotype and Amiodarone for Patients Without Extracorporeal Circulation Devices Could Be Beneficial for Those With Left Ventricular Assist Devices
16. Relationship of interleukin‐16 with different phenogroups in acute heart failure with preserved ejection fraction.
17. Relationship of Central Venous Pressure to Body Fluid Volume Status and Its Prognostic Implication in Patients With Acute Decompensated Heart Failure
18. Novel indices representing heterogeneous distributions of myocardial perfusion imaging
19. Alpha-Klotho is a novel predictor of treatment responsiveness in patients with heart failure
20. Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction
21. First Report of Electromagnetic Interference Between Percutaneous Ventricular Assist Device and Implantable Cardioverter-Defibrillator
22. Ratio of pulmonary artery diameter to ascending aortic diameter and severity of heart failure
23. Possible associations between palliative care conferences and positive outcomes when performing palliative care for patients with end-stage heart failure: a nationwide cross-sectional questionnaire survey
24. Pneumopericardium After the Removal of a Pericardiocentesis Drain
25. Abstract 14928: The Factors Impacting on Resting Energy Expenditure in Refractory Heart Failure Patients and the Probability of Urine Amino Acids Analysis as an Indicator for Calorie Intake Insufficiency
26. Abstract 13487: Impact of the New Definition of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
27. PO-05-100 DETECTION OF THE CRITICAL SUBSTRATE FOR VENTRICULAR TACHYCARDIA ABLATION WITH THE COMBINED IMAGE OF TC-99M SCINTIGRAM AND LATE IODINE ENHANCEMENT CT
28. Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction
29. Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model
30. Impact of atrial fibrillation ablation on cardiac sympathetic nervous system in patients with and without heart failure
31. Pulmonary hypertension with a precapillary component in heart failure with preserved ejection fraction
32. New Conversion Formula Between B-Type Natriuretic Peptide and N-Terminal-Pro-B-Type Natriuretic Peptide ― Analysis From a Multicenter Study ―
33. Refractory Ventricular Arrhythmias in a Patient With Dilated Cardiomyopathy Caused by a Nonsense Mutation in BAG5
34. Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction
35. Usefulness of Transient Elastography for Noninvasive and Reliable Estimation of Right-Sided Filling Pressure in Heart Failure
36. Phospholamban p.Arg14del Cardiomyopathy: A Japanese Case Series
37. Early Detection of Worsening Heart Failure in Patients at Home Using a New Telemonitoring System of Respiratory Stability
38. Usefulness of Overlapping of the E and A Waves of the Transmitral Flow as a Predictor of Responders to Cardiac Resynchronization Therapy
39. Abundant epicardial adipose tissue surrounding the left atrium predicts early rather than late recurrence of atrial fibrillation after catheter ablation
40. Long‐Term Outcomes and Clinical Predictors of Mortality Following Occurrence of Stent Thrombosis
41. Pathophysiological Evaluations of Initial Plaque Development After Heart Transplantation via Serial Multimodality Imaging and Cytokine Assessments
42. THE RELATIONSHIP BETWEEN DONOR-TRANSMITTED LIPID BURDEN AND PLAQUE PROGRESSION IN PATIENTS AFTER HEART TRANSPLANTATION
43. Diabetic Retinopathy is Associated With Impaired Left Ventricular Relaxation
44. Loss-of-function mutations in the co-chaperone protein BAG5 cause dilated cardiomyopathy requiring heart transplantation
45. Phenotyping of acute decompensated heart failure with preserved ejection fraction
46. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization
47. Impact of Body Size on Inferior Vena Cava Parameters for Estimating Right Atrial Pressure: A Need for Standardization?
48. Dynamic Nature of Nodular Calcification in Cardiac Allograft Vasculopathy
49. Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
50. Variability in estimated glomerular filtration rate and patients' outcomes in a real‐world heart failure population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.